Kromek gets funds to develop low-dose MBI technology

By staff writers

January 31, 2023 -- Radiation detection technology firm Kromek has received 2.5 million pounds (2.83 million euros) from U.K. innovation agency Innovate UK to support development of a low-dose molecular breast imaging (MBI) system based on its cadmium zinc telluride-based SPECT detectors.

Two projects will be supported. In an 18-month project worth 500,000 pounds (566.9 million euros), Kromek will work to prove the feasibility of using a single photon detector for ultralow-dose MBI. The second project, worth 2 million pounds (2.3 million euros), is a three-year program that will aim to obtain and deliver clinical data on a low-dose MBI system. It will be conducted in partnership with Newcastle-upon-Tyne Hospitals NHS Foundation Trust, the University of Newcastle-upon-Tyne, and the University College London.

The two awards follow on a previous Innovate UK-funded project conducted by Kromek and Newcastle Hospitals, according to the vendor.

Copyright © 2023

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking